Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date INNOVAtive Multi-disciplinary Clinical Management of INflammatory Diseases, 2023 IT INNOVA-MINDRelease Date:Quality Improvement Inflammation & Immunology Italy Quality Improvement in Pediatric Endocrinology FieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Employment Support / Lung CancerRelease Date:Education Oncology Japan 2023 Oncology FellowshipRelease Date:Fellowship Oncology Canada Approaches to Implement Bispecific Antibodies into Clinical Practice, Increase Awareness and Improve Delivery of Quality of CareRelease Date:Partner: Myeloma CanadaQuality Improvement Oncology Canada Improving Health Equity via Clinical Trial Capability Development in ChinaRelease Date:Education Support for the Professions China Combination Therapy with Relugolix in the Treatment of Advanced Prostate CancerRelease Date:Partner: National Comprehensive Cancer Network; Myovant SciencesResearch Oncology USA Optimizing Women’s Health Conditions in CanadaRelease Date:Quality Improvement Internal Medicine Canada Women’s HealthRelease Date:Education Internal Medicine Canada Accelerating Advancements in Women’s HealthResearch Internal Medicine USA Implementing Rapid Turnaround Time for NGS Molecular Testing for Cancer Patients in Non-Academic and Community CentresRelease Date:Partner: Colorectal Cancer Canada and Thermo Fisher ScientificQuality Improvement Oncology Canada